Continuous glucose monitoring reveals trade-off between glucose control and daily well-being
New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, shows that among people living with type 1 or type 2 diabetes, data from continuous glucose monitoring (CGM) devices paired with daily quality-of-life rat
<p>New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, shows that among people living with type 1 or type 2 diabetes, data from continuous glucose monitoring (CGM) devices paired with daily quality-of-life rat</p>